Stroke prevention study for adults 75 and older
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether adding a blood thinner called edoxaban to standard care can help prevent another stroke in people aged 75 or older who have had a stroke within the last year. It aims to see if this combination is safe and works better than standard care alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years old or older
- You had a stroke or mini-stroke (with signs on a brain scan) within the last 12 months
- Your doctor has you on aspirin or clopidogrel for stroke prevention
- You have not had any long-lasting irregular heartbeats (atrial fibrillation) when checked
- You do not have any major heart conditions that increase stroke risk, like a mechanical heart valve or a recent heart attack
- You are not currently taking blood thinners (other than aspirin or clopidogrel) or other medicines that could interact with the study drug
- You have not had major bleeding or a brain bleed in the past year, and your kidney, liver, and blood counts are within acceptable ranges
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.
This trial tests whether a lower dose of the blood thinner edoxaban can safely prevent another stroke in people aged 80 or older who have atrial fibrillation (an irregular heartbeat) and have already had a stroke or mini-stroke. It may be an option for those at higher risk of bleeding.
This study tests two different blood-thinning medicines to see which is better at preventing another stroke in people who recently had a stroke with no clear cause. The goal is to find a treatment that works well and is safe for you.
This trial tests if starting blood thinners can prevent another stroke in people who had a stroke but were found to have a hidden heart rhythm problem called atrial fibrillation. It is for older adults who have had a recent stroke without a known cause.
This study tests a blood thinner (rivaroxaban) versus usual care to see if it can prevent strokes in older adults with extra heartbeats (a sign of possible heart rhythm problems) and high stroke risk. If you qualify, the treatment might reduce your chances of having a stroke.
This study tests whether a common blood thinner (apixaban) alone is as safe and effective as combining it with another drug (clopidogrel) to prevent future strokes in people who have both atrial fibrillation and narrowing in the arteries leading to the brain. It aims to find the best way to reduce stroke risk while minimizing bleeding.
Hear when a new Stroke, Ischemic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.